]. The initial mean (SD) cysC was 1.97 (0.83) mg/L. i-GFR correlated to 1/sCr (r ϭ 0.65, P Ͻ0.001) and 1/cysC (r ϭ 0.64, P Ͻ0.001). The statistical significance was maintained when both were included in a multiple linear regression model (r ϭ 0.69, P Ͻ0.001; P ϭ 0.002 for 1/sCr and P ϭ 0.009 for 1/cysC). Areas under the ROC curves were 0.874 for cysC and 0.870 for sCr (NS). The results of the GFR estimations are presented in Table 1 .
As already reported in patients with diabetes (4 ), the performances of the CG equation (correlation with i-GFR, accuracy, area under the ROC curve, Bland-Altman procedure) were poor. In accordance with the findings of Pucci et al. (1 ) , the MDRD remains the best estimation of GFR in renally insufficient diabetic patients: the best estimates for correlation coefficient, absolute percentage difference, and ROC curve for the diagnosis of severe renal failure were all obtained with this equation. However, 1/cysC still predicted i-GFR after taking account of 1/sCr. The performances of the composite estimations of GFR, which , vs 57 (29) for the patients studied by Rule et al.] decreased the impact of the well-known underestimation of high GFR by the MDRD. Most interestingly, the correlation between the composite estimation change and the i-GFR change almost reached significance, whereas the MDRD did not. Even for advanced CKD patients, the inclusion of cysC in the composite estimation may have diagnostic value, for monitoring GFR decline, a finding that is in line with recent reports for the use of 100/cysC (5 ).
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